Preparing a submission for Investigational New Drugs
Investigational New Drugs sets its own submission rules: length and word limits, the required citation and reference style, figure and table formatting, and editorial policies. Scraiber tracks 5 requirements for Investigational New Drugs and rewrites your manuscript to meet each one.
Instead of checking each rule by hand, import your draft into Scraiber, select Investigational New Drugs, and let it rewrite your text to match: the exact word limits, reference style and structure, so your paper is submission-ready.
If the paper was rejected elsewhere, most of the work in retargeting Investigational New Drugs is mechanical: the reference style changes, headings and sections move, word and abstract limits differ, and the declarations have to follow Investigational New Drugs's own template. Scraiber applies those changes to the draft you already have instead of you rebuilding the manuscript by hand.
Manuscript types at Investigational New Drugs
Investigational New Drugs documents its author requirements per manuscript type: Cover Letter, Introductory Statement and General Investigational Plan. The rules differ between them, so Scraiber applies the set that matches the type you are submitting.
What Investigational New Drugs specifies
These are the areas Investigational New Drugs writes rules for. Scraiber holds the exact value behind each one and applies it to your draft.
- Length & word limits 1 rule: page limit.
- Formatting & submission 3 rules: cover letter, ethics statement, manuscript format.
What Scraiber changes in your manuscript
Scraiber rewrites the parts of your draft that Investigational New Drugs constrains: it brings sections within the required lengths, converts in-text citations and the bibliography to the required style, adjusts headings and structure, and flags the declarations Investigational New Drugs expects. Your argument, results and voice stay yours — only what the journal dictates changes.
Frequently asked questions
- What are the submission requirements for Investigational New Drugs?
- Investigational New Drugs has 5 documented author requirements covering length limits, citation style, figures, tables and submission policies. Sign in to Scraiber to see each exact value and rewrite your manuscript to match.
- Which citation style does Investigational New Drugs use?
- Scraiber tracks Investigational New Drugs's required reference style and reformats your citations to it automatically. Open the journal in Scraiber to apply it to your document.
- Can I automatically format my paper for Investigational New Drugs?
- Yes. Paste or import your draft into Scraiber, pick Investigational New Drugs, and it rewrites your text to meet the journal's requirements: length, references, structure and more.
- How do I reformat a paper rejected by another journal for Investigational New Drugs?
- Import the manuscript you already submitted elsewhere, select Investigational New Drugs, and Scraiber rewrites it against Investigational New Drugs's requirements: reference style, length limits, structure and declarations. You never start from a blank page.
- How long does it take to prepare a manuscript for Investigational New Drugs?
- Minutes rather than an evening. The rewrite runs on your existing draft, so what disappears is the manual pass over every formatting rule.
- Does Investigational New Drugs have different requirements per manuscript type?
- Yes. Investigational New Drugs documents separate requirements per manuscript type. Pick your type in Scraiber and it applies that set to your document.
- Do I have to redo my references for Investigational New Drugs?
- No. Scraiber converts your existing citations and bibliography to the reference style Investigational New Drugs requires, including the in-text citation format.
Official author guidelines: fda.gov